To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
A membrane oxygenator is a device used to add oxygen to, and remove carbon dioxide from the blood. It can be used in two principal modes: to imitate the function of the lungs in cardiopulmonary bypass (CPB), and to oxygenate blood in longer term life support, termed Extracorporeal membrane oxgenation, ECMO. A membrane oxygenator consists of a thin gas permeable membrane separating the blood and gas flows in the CPB circuit; oxygen diffuses from the gas side into the blood, and carbon dioxide diffuses from the blood into the gas for disposal.
Additional recommended knowledge
The history of the oxygenator, or artificial lung, dates back to 1885, with the first demonstration of a disc oxygenator, on which blood was exposed to the atmosphere on rotating discs by Von Frey and Gruber [Dorson and Loria, 1988]. These pioneers noted the dangers of blood streaming, foaming and clotting. In the 1920s and 30s, research into developing extracorporeal oxygenation continued. Working independently, Brukhonenko in the USSR and John Heysham Gibbon in the USA demonstrated the feasibility of extracorporeal oxygenation. Brukhonenko used excised dog lungs while Gibbon used a direct contact drum type oxygenator, perfusing cats for up to 25 minutes in the 1930s [Galletti, 1993].
Gibbon’s pioneering work was rewarded in May 1953 with the first successful cardiopulmonary bypass operation [Gibbon, 1955]. The oxygenator was of the stationary film type, in which oxygen was exposed to a film of blood as it flowed over a series of stainless steel plates. The disadvantages of direct contact between the blood and air were well recognised, and the less traumatic membrane oxygenator was developed to overcome these. The first membrane artificial lung was demonstrated in 1955 by the group led by Willem Kolff[Kolff and Balzer, 1955], and in 1956 the first disposable membrane oxygenator removed the need for time consuming cleaning before re-use [Kolff and Effler, 1956]. No patent was filed as Kolff believed that doctors should make technology available to all, without mind to profit [Kolff, citation needed].
The early artificial lungs used relatively impermeable polyethylene or Teflon® homogeneous membranes, and it was not until more highly permeable silicone rubber membranes were introduced in the 1960s (and as hollow fibres in 1971) that the membrane oxygenator became commercially successful [Kolobow and Bowman, 1963, Dutton et al., 1971]. The introduction of microporous hollow fibres with very low resistance to mass transfer revolutionised design of membrane modules, as the limiting factor to oxygenator performance became the blood resistance [Gaylor, 1988]. Current designs of oxygenator typically use an extraluminal flow regime, where the blood flows outside the gas filled hollow fibres, for short term life support, while only the homogeneous membranes are approved for long term use.
Dutton, R.C., et al., "Development and Evaluation of a New Hollow Fibre Membrane Oxygenator", Transactions of the American Society for Artificial Internal Organs, 17 (1971), 331-336.
Galletti, P.M., "Cardiopulmonary Bypass: A Historical Perspective", Artificial Organs 17:8 (1993), 675-686.
Gaylor, J.D.S., "Membrane Oxygenators: Current Developments in Design and Application", Journal of Biomedical Engineering 10 (1988), 541-547.
Gibbon, J.H. Chairman's address to the American Society for Artificial Internal Organs, Transactions of the American Society for Artificial Internal Organs, 1 (1955), 58-62.
Kolff, W.J., and Balzer R., "The Artificial Coil Lung", Transactions of the American Society for Artificial Internal Organs, 1 (1955), 39-42.
Kolff, W.J., and Effler, D.B., "Disposable Membrane Oxygenator (Heart-Lung Machine) and its use in Experimental and Clinical Surgery while the Heart is Arrested with Potassium Citrate According to the Melrose Technique, Transactions of the American Society for Artificial Internal Organs, 2 (1956), 13-17.
Kolobow, T., and Bowman, R.L., "Construction and Evaluation of an Alveolar Membrane Artificial Heart-Lung", Transactions of the American Society for Artificial Internal Organs, 9 (1963), 238-241.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Membrane_oxygenator". A list of authors is available in Wikipedia.|